DUBLIN, Dec. 22, 2023 /PRNewswire/ — The “Global Healthcare CMO Market (by Type, & Region): Insights and Forecast (2022-2027)” report has been added to ResearchAndMarkets.com’s offering.
The global healthcare CMO market is expected to be worth US$145.70 billion in 2023, witnessing growth at a CAGR of 12.12%, during the forecasted period.
On the basis of type, the report provides the bifurcation of the healthcare CMO market into two segments: Pharmaceutical and Medical Device. Pharmaceutical CMO segment is further divided into two segment on the basis of service: Active Pharmaceutical Ingredients (API) and Others.
The device manufacturing segment is expected to grow at the fastest rate in the market during the forecast period, owing to increasing outsourcing of device manufacturing due to a lack of in-house manufacturing facilities and complexity. CMOs have quality management systems, assembly, integration and testing capabilities besides supply chain management, experienced manufacturers have systems in place to quickly partner with health care organizations during the forecasted period.
Geographic Coverage
The global healthcare CMO market is divided into four regions: North America, Europe, Asia Pacific, and ROW. The countries covered in North America region are the US, Canada, and Mexico, while Europe includes Germany, The UK, France, Italy, Spain and Rest of the Europe. Moreover, China, Japan, India, South Korea, Rest of the Asia Pacific are included in the Asia Pacific region.
North America accounted for the maximum share of the global market. The market in North America is being driven by the region’s increased emphasis on drug discovery and manufacturing outsourcing. The region is increasing its use of scientific exploration of disease mechanisms leading to the discovery and development of agents.
Asia Pacific is predicted to grow at a significantly high rate during the forecasted period. The governments in various countries in this region are placing large contracts with local CMOs to speed up the production of life supporting devices like ventilators to counter the COVID-19 pandemic.
Medical devices like ventilator therefore become more important for providing life support to patients. Therefore, collaboration of authorities with CMOs would lead to increase in production of ventilators, this would bolster the growth of the market during the forecasted years.
Top Impacting Factors
Growth Drivers
Surging Geriatric Population
Increasing Spread of Chronic Diseases
Escalating Demand for Generic Drugs
Key Driver: Increasing Demand for Active Pharmaceutical Ingredient (API)
Over the last few years, the demand for Active Pharmaceutical Ingredient (API) manufacturing has been steadily increasing. It is expected to rise steadily in the future, with additional patent expirations and a significant increase in global generic production capacities. Increasing government initiatives in the healthcare sector, biologics innovation, and an increase in the incidence of cancer and age-related diseases are some of the major factors driving the growth of the API manufacturing. The majority of the industry’s companies are increasingly focusing on the development of biological APIs, which is propelling the API manufacturing. The growing emphasis on high-potency APIs is increasing the demand for API manufacturing. Novel HPAPI technologies have the potential to change the in-out balance of CMOs in this rapidly growing segment. As large pharmaceutical companies continue to reduce manufacturing, better opportunities for CMOs in the biopharmaceutical and small molecule API sectors are expected, driving the market growth.
Challenges
Dependent on Patents, Copyrights, Trademarks and Trade Secrets
Key Challenge: Rapid Technological Advancements
The healthcare industry is characterized by rapid technological change. Demand for company’s offerings may change in ways the company may not anticipate because of evolving industry standards as well as a result of evolving customer needs that are increasingly sophisticated and varied and the introduction by others of new offerings and technologies that provide alternatives to the offerings. Several of the higher margin offerings are based on proprietary technologies. To the extent that such technologies are protected by patents, their related offerings may become subject to competition as the patents expire. Without the timely introduction of enhanced or new offerings and technologies, the offerings may become obsolete or uncompetitive over time, this may impact the operation of the company and correspondingly obstructs market growth.
Trends
Evolution of Advanced Respiratory Equipment
Key Trend: Escalating Role of Artificial Intelligence Technology
Healthcare artificial intelligence (AI) has transformed by assisting in repetitive tasks, designing treatment plans, medication management, and drug discovery. It can also be effectively used for healthcare data management by collecting, storing, and normalizing the data. Contract manufacturers are incorporating AI and other technological innovations to become more cost-effective and speed up production time. In addition pharmaceutical CMOs are constantly developing AI technology in order to facilitate better risk detection and, in turn, improve the quality and safety of pharmaceutical products. The growth of the AI industry would correspondingly bolster the growth of the global healthcare CMO market.
Key player analysis includes:
Catalent Pharma Solutions
Samsung Biologics
Aurobindo Pharma
Boehringher Ingelheim
Integer Holdings
Piramal Enterprises
Lonza Group
Koninklijke
Thermo Fisher Scientific
Recipharm
Fareva Group
Symbiosis Pharmaceutical Services
Key Topics Covered:
1. Executive Summary
2. Introduction
2.1 Healthcare Contract Manufacturing Organization (CMO): An Overview
2.1.1 Benefits Of Healthcare CMOs
2.2 Healthcare CMO Segmentation: An Overview
2.2.1 Healthcare CMO Segmentation
3. Global Market Analysis
3.1 Global Healthcare Contract Manufacturing Organization (CMO) Market: An Analysis
3.2 Global Healthcare CMO Market: Type Analysis
4. Regional Market Analysis
5. Impact of COVID-19
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Surging Geriatric Population
6.1.2 Rising Healthcare Expenditure
6.1.3 Increasing Spread of Chronic Diseases
6.1.4 Escalating Demand for Generic Drugs
6.1.5 Growing Inclination Towards Herbal Products
6.1.6 Increasing Demand for Active Pharmaceutical Ingredient (API)
6.2 Challenges
6.2.1 Rapid Technological Advancements
6.2.2 Dependent on Patents, Copyrights, Trademarks and Trade Secrets
6.3 Market Trends
6.3.1 Escalating Role of Artificial Intelligence Technology
6.3.2 Evolution of Advanced Respiratory Equipment
7. Competitive Landscape
7.1 Global Healthcare CMO Market Players Financial Comparison
7.2 Global Healthcare CMO Market Players by Research & Development (R&D) Expenses
8. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/ei62bq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
